Treatment of Vincristine-Induced Bilateral Ptosis with Pyridoxine and Pyridostigmine

Pediatric Blood and Cancer

Volumn 42, Issue 3, 2004, Pages 287-288

  Müller, Lars ^a   Kramm, Christof M ^a   Tenenbaum, Tobias ^a   Wessalowski, Rüdiger ^a   Göbel, Ulrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Ptosis; Pyridostigmine; Pyridoxine; Vincristine neuropathy

Indexed keywords

DOXORUBICIN; IFOSFAMIDE; PYRIDOSTIGMINE; PYRIDOXINE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; DRUG COMBINATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FOLLOW UP; HUMAN; IATROGENIC DISEASE; MALE; METHODOLOGY; NECK DISSECTION; NEUROPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; PTOSIS; REMISSION; SURVIVAL; SYMPTOM; SYNOVIAL SARCOMA;

EID: 1242272094     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10301     Document Type: Article

References (5)

1. Spillane AJ, A'Hern R, Judson IR, et al. Synovial sarcoma: A clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000;18:3794-3803.
2. Jackson DV, Jr., Pope EK, McMahan RA, et al. Clinical trial of pyridoxine to reduce vincristine neurotoxicity. J Neurooncol 1986;4:37-41.
3. Battle WM, Cohen JD, Snape WJ, Jr. Disorders of colonic motility in patients with diabetes mellitus. Yale J Biol Med 1983;56:277-283.
4. Battle WM, Snape WJ, Jr., Alavi A, et al. Colonic dysfunction in Diabetes mellitus. Gastroenterology 1980;79:1217-1221.
5. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol 2002;249:9-17.